George Magrath serves as Executive at Ocuphire Pharma, Inc., where they oversee executive responsibilities. Since joining the company, George Magrath has executed 6 insider transactions totaling $57.8K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jan 22, 2026 involved receiving (via award) 483,639 shares valued at $0.
George Magrath currently holds 1,775,293 shares of Ocuphire Pharma, Inc. (OCUP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, George Magrath has been a net buyer of OCUP stock. They have purchased $57.8K and sold $0 worth of shares.
George Magrath's most recent insider trade was on Jan 22, 2026, when they sold 483,639 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $2.30 |
| Discretionary |
| Nov 1, 2025 | IRD | $69.8K | Payment | 30,350 | $2.30 | Discretionary |
| May 17, 2024 | OCUP | $8.8K | Purchase | 5,000 | $1.75 | Discretionary |
| Mar 18, 2024 | OCUP | $49.0K | Purchase | 25,000 | $1.96 | Discretionary |
| Nov 1, 2023 | OCUP | $0 | Award | 400,000 | $N/A | Discretionary |